Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Phentermine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for phentermine hydrochloride and what is the scope of phentermine hydrochloride patent protection?

Phentermine hydrochloride
is the generic ingredient in eleven branded drugs marketed by Vitarine, Able, Usl Pharma, Sandoz Inc, Tg United Labs, Sandoz, Ken Lifescience, Mast Mm, Abc Holding, Teva, Invagen Pharms, Aurolife Pharma Llc, Lannett, Sun Pharm Inds, Camall, Mikah Pharma, Mikah Pharma Llc, Ivax Pharms, Solvay, Kvk Tech Inc, Watson Labs, Polygen Pharms, Ferndale Labs, Duramed Pharms Barr, Elite Labs, Ingenus Pharms Nj, Glaxosmithkline, Lannett Holdings Inc, Shire Richwood, Barr, Kvk Tech, Actavis Elizabeth, Prinston Inc, Tg United Inc, Citius Pharms, Sun Pharm Inds Inc, Avanthi Inc, and Vivus, and is included in ninety-nine NDAs. There are fourteen patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Phentermine hydrochloride has twelve patent family members in ten countries.

There are seventeen drug master file entries for phentermine hydrochloride. Forty-eight suppliers are listed for this compound.

Summary for Generic Name: phentermine hydrochloride

Tradenames:11
Patents:14
Applicants:38
NDAs:99
Drug Master File Entries: see list17
Suppliers / Packagers: see list48
Bulk Api Vendors: see list24
Clinical Trials: see list1,001
Patent Applications: see list1,035
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:phentermine hydrochloride at DailyMed

Pharmacology for Ingredient: phentermine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kvk Tech
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
CAPSULE;ORAL040875-001Mar 21, 2008AARXNoNo► Subscribe► Subscribe
Citius Pharms
SUPRENZA
phentermine hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL202088-003Mar 27, 2012DISCNNoNo8,440,170► SubscribeY ► Subscribe
Vivus
QSYMIA
phentermine hydrochloride; topiramate
CAPSULE, EXTENDED RELEASE;ORAL022580-001Jul 17, 2012RXYesNo6,071,537► Subscribe ► Subscribe
Able
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
CAPSULE;ORAL040497-001Mar 13, 2003DISCNNoNo► Subscribe► Subscribe
Abc Holding
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
CAPSULE;ORAL085411-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot